| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2005;46:1140.)
© 2005 American Heart Association, Inc.
Original Articles |
From the Second Department of Internal Medicine (T.O., M.T., M.S., R.M., S.S., H.T., N.M, K.O.), Hirosaki University School of Medicine, Hirosaki, Japan; Daiichi Suntory Biomedical Research Co, Ltd (K.M.), Osaka, Japan.
Correspondence to Tomohiro Osanai, MD, the Second Department of Internal Medicine, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562 Japan. E-mail osanait{at}cc.hirosaki-u.ac.jp
Coupling factor 6 (CF6), a component of adenosine triphosphate (ATP) synthase, is circulating and functions as an endogenous vasoconstrictor by inhibiting cytosolic phospholipase A2. We showed a high plasma level of CF6 in human hypertension. The present study focused on the identification and characterization of a receptor for CF6 and its post-receptor signaling pathway. Incubation of human umbilical vein endothelial cells (HUVECs) with an excess of free CF6 reduced by 50% the immunoreactivity for the antibody to ß-subunit of ATP synthase at the cell surface, but unaffected that for the
-subunit antibody. A significant displacement of radioligand was observed at 3x109 through 107 M unlabeled CF6, and the Kd was 7.6 nM. Adenosine diphosphate (ADP) at 107 M and ß-subunit antibody suppressed the binding of 125I-CF6 by 81.3±9.7% and 32.0±2.0%, respectively, whereas the
-subunit antibody unaffected it. The hydrolysis activity of ATP to ADP was increased by 1.6-fold by CF6 at 107 M, and efrapeptin at 105 M, an inhibitor of ATP synthase, blocked it. CF6 at 107 M decreased intracellular pH in 2',7'-bis(carboxyethyl-5 (6))-carboxyfluorescein-loaded HUVEC. Amyloride at 104 M augmented the pH decrease in response to CF6, whereas efrapeptin at 105 M blocked it. Arachidonic acid release was suppressed by CF6, and it was reversed by efrapeptin at 105 M or ß-subunit antibody or ADP at 107 M. The ß-subunit antibody suppressed coupling factor 6induced increase in blood pressure. These indicate that membrane-bound ATP synthase functions as a receptor for CF6 and may have a previously unsuspected role in the genesis of hypertension by modulating the concentration of intracellular hydrogen.
Key Words: hypertension prostacyclin
Related Article:
Hypertension 2005 46: 1100-1102.
This article has been cited by other articles:
![]() |
T. Osanai, H. Tomita, M. Kushibiki, M. Yamada, M. Tanaka, T. Ashitate, T. Echizen, C. Katoh, K. Magota, and K. Okumura Coupling factor 6 enhances Src-mediated responsiveness to angiotensin II in resistance arterioles and cells Cardiovasc Res, March 1, 2009; 81(4): 780 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hong and P. L. Pedersen ATP Synthase and the Actions of Inhibitors Utilized To Study Its Roles in Human Health, Disease, and Other Scientific Areas Microbiol. Mol. Biol. Rev., December 1, 2008; 72(4): 590 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-H. Zhang, V. S. Kamanna, M. C. Zhang, and M. L. Kashyap Niacin inhibits surface expression of ATP synthase {beta} chain in HepG2 cells: implications for raising HDL J. Lipid Res., June 1, 2008; 49(6): 1195 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Watts Vasoconstriction Caused by the ATP Synthase Subunit-Coupling Factor 6: A New Function for a Historical Enzyme Hypertension, November 1, 2005; 46(5): 1100 - 1102. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |